1. 3328 A randomized controlled phase II clinical trial on autologous monocyte-derived mRNA electroporated dendritic cells for stage III/IV melanoma patients who are disease-free following the local treatment of macrometastases. (September 2015) Authors: Jansen, Y.; Corthals, J.; Wilgenhof, S.; Schreuer, M.; Heirman, C.; Thielemans, K.; Neyns, B. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Micromanaging Atherosclerosis: Vascular Cell-Specific Microrna-26b Attenuates Atherosclerosis Development. (August 2019) Authors: Peters, L.; Bidzhekov, K.; Jansen, Y.; Haberbosch, M.; Gencer, S.; Müller, M.; Bayasgalan, S.; Megens, R.; Döring, Y.; Weber, C.; Van der Vorst, E. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Endothelial Atypical Chemokine Receptor-3 Is A Novel Driver Of Atherosclerosis. (August 2019) Authors: Gencer, S.; van der Vorst, E.; Jansen, Y.; Bianchini, M.; Peters, L.; Müller, M.; Bayasgalan, S.; Megens, R.; Söhnlein, O.; Döring, Y.; Weber, C. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Data to Physicalization: A Survey of the Physical Rendering Process. (29th June 2021) Authors: Djavaherpour, H.; Samavati, F.; Mahdavi‐Amiri, A.; Yazdanbakhsh, F.; Huron, S.; Levy, R.; Jansen, Y.; Oehlberg, L. Journal: Computer graphics forum Issue: Volume 40:Number 3(2021) Page Start: 569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium. (August 2022) Authors: Gencer, S.; Jansen, Y.; Bayasgalan, S.; Yan, Y.; Bianchini, M.; Cimen, I.; Müller, M.; Peters, L.; Megens, R.; Duchene, J.; Lemnitzer, P.; Soehnlein, O.; Weber, C.; Doering, Y.; Van Der Vorst, E. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Micromanaging atherosclerosis: Myeloid cell-specific microRNA-26b attenuates atherosclerosis development. (August 2022) Authors: Peters, L.; Bidzhekov, K.; Jansen, Y.; Bayasgalan, S.; Gencer, S.; Sundararaman, S.S.; Bonnin-Marquez, A.; Yan, Y.; Jans, A.M.; Bartneck, M.; Doering, Y.; Weber, C.; Van Der Vorst, E. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Endothelial cannabinoid receptor CB1 deficiency decreases oxLDL uptake and attenuates vascular inflammation in atherosclerosis. (August 2022) Authors: Chen, B.; Prats, R. Guillamat; Li, G.; Jansen, Y.; Prabhu, A.; Remco, M.; Lutz, B.; Hofmann, S.; Herzig, S.; Steffens, S. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Myeloid cannabinoid receptor CB1 deficiency limits macrophage proliferation and atherosclerosis in a sex-specific manner. (August 2022) Authors: Wang, Y.; Guillamat Prats, R.; Li, G.; Lacy, M.; Jansen, Y.; Lutz, B.; Herzig, S.; Steffens, S. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Unravelling the role of vascular chemR23 expression in atherosclerosis. (August 2021) Authors: Evans, B.R.; Yan, Y.; Van Der Vorst, E.; Gencer, S.; Jansen, Y.; Thakur, M.; Weber, C.; Döring, Y. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. B-cell specific CXCR4 protects against atherosclerosis development by controlling plasma IGM levels. (December 2020) Authors: Döring, Y.; Jansen, Y.; Aslani, M.; Gencer, S.; Peters, L.; Duchene, J.; Weber, C.; Van Der Vorst, E. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗